Agilent Technologies Inc.’ Thought Leader Award Supports Dr. Robert Gerszten’s Work in Metabolomic Research at Massachusetts General Hospital

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Dr. Robert Gerszten, a recognized leader in cardiovascular research and biomarker discovery, has received an Agilent Thought Leader Award.

Back to news